Aberdeen Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
303,426
+170,993
| +129% | +$1.6M | ﹤0.01% | 757 |
|
|
2025
Q1 | $1.63M | Buy |
132,433
+33,093
| +33% | +$407K | ﹤0.01% | 777 |
|
|
2024
Q4 | $1.31M | Buy |
+99,340
| New | +$1.31M | ﹤0.01% | 800 |
|
|
2021
Q4 | – | Sell |
-14,248
| Closed | -$272K | – | 1068 |
|
|
2021
Q3 | $272K | Buy |
+14,248
| New | +$272K | ﹤0.01% | 1010 |
|